Skip to main content
Equibles

BIOGEN · BIOGEN PHARMACHEM INDUSTRIES L · Financials

Use BIOGEN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BIOGEN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
0.29 INR -0.01 (-3.33%) At close · Nov 13
Rebalance outlook locked
Market Cap
305.38M INR
Shares
1.05B
Volume · Nov 13 9.42M Avg daily vol (3M) 4.37M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
25.58M +205.1%
FY2026 Revenue FY2025–FY2026
Net Income
8.59M +393.6%
FY2026 Net Income FY2025–FY2026
Operating Cash Flow
15.68M +243.7%
FY2026 Operating Cash Flow FY2025–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025
INR 10.22M 25.58M 8.38M
INR 0 0 0
INR 5.82M 9.57M -2.93M
INR 0 973K 0
INR 5.82M 8.59M -2.93M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.